Lighter You review

Lighter You advertises tirzepatide "starting at $169/mo" on its marketing site. Its own store charges $339 for four weeks of it. Both were live in September 2026, on the same brand, on the same day — and the same gap, in the same direction, runs through almost every product it sells.

The good news first: the store publishes a price per product, per dose, before any intake, which is more than many sellers do. That is also what makes the gap easy to see.

What is advertised, and what is charged

Semaglutide is the one figure that matches. Tirzepatide is exactly double what is advertised. The low-dose line is advertised at a number no product in it costs, and the advertised figure is $83 below the real one on every single item.¹

A fourth price list exists on a peptide sub-brand run by the same company, and it prices the shared side products differently again. So a shopper can meet three different numbers for the same item without leaving the operator.

"/mo" is four weeks

The marketing site writes "/mo". The store writes "per 4 week". Four-week billing comes round thirteen times a year, not twelve — so even the semaglutide figure that does match is about $2,197 a year rather than $2,028, and tirzepatide is about $4,407 rather than $4,068. The teaser-rate trap covers why a cadence stated in one place and implied differently in another is worth as much attention as the number itself.

What the gap means for a price ranking

Lighter You appears on the semaglutide price ladder at its store price, not its advertised one — $169 per four weeks, the figure a buyer is actually charged. Its tirzepatide price is listed at $339 for the same reason.

The rule we apply everywhere: when a seller's marketing and its checkout disagree, the checkout is the price.

What it is, though — because it is not a shell

Lighter You names three pharmacies, with street addresses and phone numbers: RedRock Pharmacy in St. George, Utah; Health Warehouse in Florence, Kentucky; and Precision Compounding Pharmacy. That is better supply-chain disclosure than most of the market manages, and considerably better than the sellers that name none. Its intake consent names OpenLoop Health as the clinical layer, and its legal pages are complete rather than boilerplate.

It also displays a certification badge. A badge alone does not show who holds the certification, so look the seal up on the certifier's own site before you rely on it.

So the problem here is not that nobody is home. It is that a company doing the checkable parts properly is advertising a price it does not charge.

The contradictions

The terms say services are offered "in all 50 states plus Washington D.C.". The footer, on every page of the same site, says "Not available in all 50 states." Both sentences are live, and no exclusion list is published.

The questions promise a month-to-month membership with a 30-day satisfaction guarantee. The refund policy contradicts it in block capitals: in no event shall a refund be issued on cancellation. Cancellation requires 72 hours' notice before the billing date, and the effect lands on the cycle after that.

And you are charged when you complete the intake, before a provider reviews it. Combine that with the refund clause and the practical position is that your first payment is at risk from the moment you submit.

A badge on the homepage says purchases are eligible for a tax-advantaged health account. The terms decline to guarantee that any amount paid is eligible for reimbursement by insurance or by such an account.

Who is prescribing

Nobody is named. No clinician, no medical group, no identifier, and no statement of which of the three named pharmacies fills a given order. Lighter You, LLC publishes no address. How to verify a compounding pharmacy is legitimate is the check you can partly run here, because the pharmacies have names; the prescriber half of it, you cannot run at all.

FDA warning letters

The FDA has issued no warning letter to Lighter You, its three named pharmacies or its clinical partner (checked September 2026).² A search for "lighter you" does turn up a February 2026 letter, but it went to an unrelated tobacco company with a similar name.

The verdict for a bargain hunter

Semaglutide at $169 for four weeks is a fair mid-field price and the advertised figure is honest on that one product. Everything else on the shelf costs more than the page that sold it to you said. Budget thirteen charges a year, price the product you actually want in Lighter You's store ↗ rather than on the marketing site, and read how to choose a GLP-1 provider without overpaying before you submit an intake that charges your card. The rest of what we publish is in the research library.